Pfizer

Industries Pharmaceuticals Biotechnology and Life Sciences
Subsidiaries Array BioPharma Inc.
Location Washington, D.C.

Headquartered in New York, Washington, D.C., Pfizer is a member of the Fortune 250 operating in the Pharmaceuticals Biotechnology and Life Sciences industry. Albert Bourla DVM Ph.D. serves as CEO/President and Chairman, leading the company’s C-suite executive team and the board of directors. Amongst these teams, the collective leadership is responsible for $269,500 to Republican causes and $1,524,244 to Democratic causes. Under their tenure, Pfizer currently holds a ‘High’ rating.

Business Roundtable
Catalyst's Champions for Change
CEO Action Pledge

Company Leadership

Albert Bourla DVM Ph.D.
CEO & Chairman at Pfizer

Albert Bourla DVM Ph.D.

Albert Bourla has been affiliated Pfizer for more than 30 years, currently serving as the Chief Executive Officer. His other affiliations include the International Federation of Pharmaceutical Manufacturers & Associations, the United States Council for International Business, the Council on Foreign Relations, The Business Council and The Business Roundtable. He holds a Ph.D. in the Biotechnology of Reproduction from the Veterinary School of Aristotle University, a Doctor of Philosophy in Biotechnology of Reproduction from Aristotle University of Thessaloniki, a Doctor of Veterinary Medicine, Honorary Doctorate from American College of Greece, an Honorary Doctorate from the University of Patras, an Honorary Doctorate from Touro University, an Honorary Doctorate from The Technion-Israel Institute of Technology, an Honorary Doctorate from Aristotle University, and Honorary Doctorate from Babson College.

Political Contributions of Leadership

Republican Support
Democratic Support
$269,500 $1,524,244

Leadership

No photo: Albert Bourla DVM Ph.D.
Exec. Board

Chairman & CEO

Albert Bourla DVM Ph.D.

Shantanu Narayen
Exec. Board

Chairman & CEO

Shantanu Narayen

James Quincey
Exec. Board

Chairman and CEO

James Quincey

No photo: Liz Forminard
Exec.

Exec VP, General Counsel

Liz Forminard

Sally Susman
Exec.

Chief Corporate Affairs Officer, President

Sally Susman

Aamir Malik
Exec.

Chief Business Innovation Officer, Exec VP

Aamir Malik

No photo: Dave Denton
Exec.

CFO and Exec VP

Dave Denton

No photo: Doug Lankler
Exec.

General Counsel, Exec VP

Doug Lankler

No photo: Lidia Fonseca
Exec.

Chief Digital and Technology Officer, Exec VP

Lidia Fonseca

No photo: Mikael Dolsten, MD, Ph.D.
Exec.

Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer Inc.

Mikael Dolsten, MD, Ph.D.

No photo: Mike McDermott
Exec.

Chief Global Supply Officer, Exec VP

Mike McDermott

No photo: Payal Sahni Becher
Exec.

Chief People Experience OFficer, Exec VP

Payal Sahni Becher

No photo: Rady Johnson
Exec.

Chief Compliance, Quality and Risk Officer, Exec VP

Rady Johnson

No photo: Angela Hwang
Exec. Board

Chief Commercial Officer, President, Global Biopharmaceuticals Business

Angela Hwang

No photo: Yin Becker
Exec.

VP, Chief Corporate Affairs Officer

Yin Becker

No photo: Joseph J. Echevarria
Board

Board Member

Joseph J. Echevarria

No photo: Dan R. Littman, MD, Ph.D.
Board

Board Member

Dan R. Littman, MD, Ph.D.

No photo: Helen H. Hobbs, MD
Board

Board Member

Helen H. Hobbs, MD

No photo: James C. Smith
Board

Board Member

James C. Smith

Ronald E. Blaylock
Board

Board Member

Ronald E. Blaylock

No photo: Scott Gottlieb, MD
Board

Board Member

Scott Gottlieb, MD

No photo: Susan Desmond-Hellmann, MD, MPH
Board

Board Member

Susan Desmond-Hellmann, MD, MPH

No photo: Susan Hockfield, Ph.D.
Board

Board Member

Susan Hockfield, Ph.D.

No photo: Suzanne Nora Johnson
Board

Board Member

Suzanne Nora Johnson